KIDNEY INT 润色咨询

KIDNEY INTERNATIONAL

出版年份:暂无数据 年文章数:2715 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:5.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2020-05-11 Abby2016

    请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2017-04-22 xh01

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据;
    2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据;
    2017年4月初第二次修回,3天后接收。
    总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2021-06-22 1e1e3459m09(暂无匿称)

    偏重的研究方向:肾缺血再灌注损伤
    经验分享:第一次投稿KI,记录下,希望能有好运~
    ① 6-21 22:30左右投稿,状态:
    ME:××
    PROD:Not Assigned
    Awaiting Admin Processing
    ② 6-22 16:30左右 更新状态:
    ME:××
    ME:××
    PROD:Not Assigned
    Under Review

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2023-11-04 1de6be33m00(暂无匿称) 来自湖南省

    投稿命中率:25.0
    经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2023-06-18 ms8000001405624126 来自广东省

    06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    被拒了3次了

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2019-09-01 wangqifjz

    投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2023-09-13 ms3000000962514522 来自浙江省

    四十多天了还没有回来,不知道等多久,忐忑。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2015-09-13 211.97.5.59

    再接再厉!JerryChancw 2015-03-02 发表::
    研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事

    JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=590624, encodeId=e1c759062488, content=请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2016年11月初投稿,3周发回审稿意见,大修,修稿意见多达4页,要求补充大量数据; <br> 2017年3月初修回,2周发回审稿意见,一位审稿人满意了,另一位审稿人仍要求补充一些数据; <br> 2017年4月初第二次修回,3天后接收。 <br> 总体感觉:该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高,且极为认真,提出的意见都很中肯。不过真心挺难投中的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975848, encodeId=69a99e58489a, content=偏重的研究方向:肾缺血再灌注损伤<br>经验分享:第一次投稿KI,记录下,希望能有好运~<br>① 6-21 22:30左右投稿,状态:<br>ME:××<br>PROD:Not Assigned<br>Awaiting Admin Processing<br>② 6-22 16:30左右 更新状态:<br>ME:××<br>ME:××<br>PROD:Not Assigned<br>Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170110/IMG5874F4DFD1FFA3596.jpg, createdBy=5f022008211, createdName=1e1e3459m09(暂无匿称), createdTime=Tue Jun 22 17:05:10 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0<br>经验分享:投稿后1天under review,9天后就awaiting ED desicion了,等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2143567, encodeId=8d08214356ee6, content=06-07投的,第二天就Under Review,现在11天了没有更新状态,要等多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a1f8740091, createdName=ms8000001405624126, createdTime=Sun Jun 18 23:46:35 CST 2023, time=2023-06-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=578585, encodeId=2efd5e858584, content=被拒了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天 一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157471, encodeId=b083215e47170, content=四十多天了还没有回来,不知道等多久,忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9685507100, createdName=ms3000000962514522, createdTime=Wed Sep 13 06:43:33 CST 2023, time=2023-09-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉!<span class="quote">JerryChancw 2015-03-02 发表::<br>研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事</span>, beContent=JerryChancw 2015-03-02 发表:: 研究方向:盐敏感性高血压;; 接收率:约5% 审稿时间:约1个月 3天被拒,不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590627, encodeId=e2b859062e96, content=现在这个状态已经半个月了<span class="quote">绿色撒哈拉 2020-05-11 发表::<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span><span class="quote">绿色撒哈拉 2020-05-11 00:00:00 发表:<br>请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?</span>, beContent=绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIYNibZjpQPzlUCSZSW1fTX1RuFWAicjHg6tW6aY1tibRV7iaWJ6H0YrTV1odibZwDyjibqiakMfeI8spmPQ/132, createdBy=aa715317239, createdName=Abby2016, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=)]
    2020-05-11 Abby2016

    现在这个状态已经半个月了绿色撒哈拉 2020-05-11 发表::
    请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?
    绿色撒哈拉 2020-05-11 00:00:00 发表:
    请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?

    绿色撒哈拉 2020-05-11 发表:: 请了解KI投稿流程的前辈指点,投稿第三天变成如下状态: ME:XXX, ME: XXX PROD: Not Assigned Under Review KI的审稿一般还是比较快的,不知道会不会受疫情影响。这个状态是送没送外审呢?我没有推荐审稿人,是不是找不到审稿人?还是编辑觉得没兴趣,还没开始处理?

    1

    展开1条回复
共60条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分